Peptide APIs
Liraglutide
CAS No.
204656-20-2
A GLP-1 receptor agonist peptide used in injectable formulations for type 2 diabetes and chronic weight management.
Liraglutide is a fatty-acid-acylated GLP-1 analogue peptide API manufactured by NovaAcura Biotech under stringent GMP quality systems appropriate to peptide API handling. Full batch documentation and regulatory support are available for global formulation partners.
Applications & Uses
A GLP-1 receptor agonist peptide used in injectable formulations for type 2 diabetes and chronic weight management.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch